The recombinant allergen Fel d 1 detected 22 positive sera out of 25 (82% incidence) with higher prevalence of sera with titers of 0.70-3.5 IU/ml (international unites per milliliter; 1 IU is equivalent to 2.42 ng of IgG).
Possible Applications: Western Blot (WB), Dot Blot (DB), Indirect ELISA, Positive Control in Direct ELISA, Chemiluminescence Immunoassays (CLIA), Lateral Flow (LF). Where this product has not been tested for use in a particular technique, this does not necessarily include its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates. The lab strongly recommends utilizing anti-CCD (cross-reactive-carbohydrate determinants) absorbent to eliminate the anti-CCD IgE antibodies present in normal human sera to prevent cross-reaction of this glycoprotein. By using this absorbent, reactions resulting from CCDs are stopped. In the specific case, you measure IgG with an allergen produced in P. pastoris, the lab recommends using an anti-CCD sorbent (Please Inquire) to avoid cross-reaction with antibodies in sera which react with fungal high mannose glycans.
- Composition: recombinant allergen with a his-tag
A0.1% (=1 g/l) = 0.593
Concentration*: 1.48 mg/mL
*The measurement of the protein concentration has been performed with the theoretical extinction coefficient of the recombinant protein obtained from Gill and vonHippel, 1989. It is recommended that the users carry out their absorbance determinations to avoid equipment variabilities regarding final concentration, mainly in reproducibility analysis.
Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem. 1989 Nov 1;182(2):319-26.
Similar Products
Product Notes
The Fel d 1 (Catalog #AAA505101) is a Recombinant Protein produced from Pichia pastoris and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's Fel d 1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). The evaluation of the recombinant allergen has been evaluated in an external study carried out at a Spanish hospital by a group of allergists with positive and negative serum samples from patients. The evaluation of the recombinant allergens has been performed by means of an in-house ELISA assay. In this immunoassay, it has been determined the presence of specific IgG in sera that had previously been validated by skin prick testing (SPT) and the UniCAP® test. The sera panel for this study was composed of 25 positive and 10 negative specimen sera. The recombinant allergen Fel d 1 detected 22 positive sera out of 25 (82% incidence) with higher prevalence of sera with titers of 0.70-3.5 IU/ml (international unites per milliliter; 1 IU is equivalent to 2.42 ng of IgG). Possible Applications: Western Blot (WB), Dot Blot (DB), Indirect ELISA, Positive Control in Direct ELISA, Chemiluminescence Immunoassays (CLIA), Lateral Flow (LF). Where this product has not been tested for use in a particular technique, this does not necessarily include its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates. The lab strongly recommends utilizing anti-CCD (cross-reactive-carbohydrate determinants) absorbent to eliminate the anti-CCD IgE antibodies present in normal human sera to prevent cross-reaction of this glycoprotein. By using this absorbent, reactions resulting from CCDs are stopped. In the specific case, you measure IgG with an allergen produced in P. pastoris, the lab recommends using an anti-CCD sorbent (Please Inquire) to avoid cross-reaction with antibodies in sera which react with fungal high mannose glycans. Researchers should empirically determine the suitability of the Fel d 1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Fel d 1, Recombinant Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.